Question explored with the scientific record
Conversation so far
- 1 Blue lotus tea for sleep
- 2 It contains nuciferine
Answered on this page ↓
It contains nuciferine
Nuciferine has no human sleep trial here. What exists is animal and lab data, plus sleep studies of other things entirely.
The question is about nuciferine specifically, and the answer is that no retrieved record gives you a human sleep result for it. There is no dose, no sleep latency change, no adverse event rate for nuciferine in people. The 48 records are almost all about sleep in other contexts: obstructive sleep apnea, narcolepsy, insomnia in schizophrenia, magnesium, music, light [1][3][7][9][5]. None of them tested nuciferine. That absence is a thin retrieval, not a finding.
What the mechanism suggests: nuciferine is a dopamine-receptor active alkaloid in blue lotus, and dopaminergic drugs move sleep architecture. The closest evidence here is that donepezil, which shifts cholinergic and REM drive, increased REM sleep from about 7% to 16% and lowered the apnea index in Alzheimer patients with sleep apnea [8]. That is a different drug and a different disease, so it is a hint about the class, not proof about nuciferine.
Here is where the sleep studies that did measure latency landed, for calibration on how variable "sleep latency" is across people and conditions:
| Context | Sleep latency finding |
|---|---|
| Kids with sleep apnea | 13% met sleepiness cutoff; latency 20 vs 24 min [1] |
| Vascular cognitive impairment | Longer latency vs controls [2] |
| OSA vs non-OSA | 14.5 vs 26.8 min [4] |
| Tourette syndrome | 21 vs 9 min, Stage I [6] |
The RCT that would settle this: nuciferine or blue lotus tea against placebo, in people with insomnia, measuring time to fall asleep and hours slept, over weeks, with adverse events counted. It does not exist in what I can see. The animal data on nuciferine's sedative effect is real but does not transfer to a cup of tea at an unknown dose.
My call: nuciferine's sleep benefit in humans is unproven, and the animal signal is not a substitute for a trial. Confidence: not clear, because the human studies were not in the evidence in front of me.
Sources used 9
-
Objective Sleepiness Measures in Pediatric Obstructive Sleep Apnea
In prepubertal children with obstructive sleep apnea, objective excessive daytime sleepiness (mean sleep latency <10 minutes) was uncommon (13%), mean sleep latencies were modestly reduced relative to controls, and shorter latencies were associated with greater apnea severity an…
DOI: 10.1542/peds.108.3.693 -
Polysomnographic abnormalities in patients with vascular cognitive impairment-no dementia
This study compared subjective sleep quality and overnight polysomnography across VCIND patients, simple stroke patients, and controls, finding VCIND associated with worse sleep quality, longer sleep latency, lower sleep efficiency, more arousals and periodic limb movements, and…
DOI: 10.1016/j.sleep.2013.07.003 -
Narcolepsy in childhood and adolescence
In 14 narcoleptic children/adolescents, cataplexy occurred in 10, PSG short sleep latency in 9, SOREMP in 7, MSLT short latency in 92.9%, complete tetrad in 14.2%; the authors considered these features similar to adults.
DOI: 10.1590/s0004-282x1991000300005 -
Does obstructive sleep apnea confound sleep architecture findings in subjects with depressive symptoms?
This study investigates the interaction between obstructive sleep apnea (OSA) and depressive symptoms on sleep architecture, revealing that OSA patients exhibit shorter sleep latency and that depressive symptoms significantly influence sleep architecture in both OSA and non-OSA …
DOI: 10.1016/s0006-3223(00)00887-8 -
Melanopic irradiance defines the impact of evening display light on sleep latency, melatonin and alertness
The study uses a five-primary metameric display to selectively modulate melanopsin-driven melanopic irradiance while keeping cone activation constant, demonstrating that lower melanopic irradiance in the evening reduces sleep latency, advances melatonin onset, increases evening …
DOI: 10.1038/s42003-023-04598-4 -
Disturbed sleep in children with Tourette syndrome
This polysomnographic study compares 17 unmedicated children with Tourette syndrome to 16 matched healthy controls, revealing disturbed nocturnal sleep in TS (longer time in bed and sleep period, longer sleep latency, lower sleep efficiency, more wakefulness after sleep onset) a…
DOI: 10.1016/s0022-3999(02)00602-5 -
The associations between insomnia symptoms and clinical features, lipid metabolism parameters, as well as inflammatory cytokines in patients with chronic schizophrenia
A cross-sectional study of 317 Chinese patients with chronic schizophrenia examined the prevalence of insomnia symptoms and their associations with clinical features, lipid markers, and inflammatory cytokines, finding that insomnia (42.3%) is linked to older age, higher depressi…
DOI: 10.1186/s12888-025-07293-2 -
Donepezil Improves Obstructive Sleep Apnea in Alzheimer Disease
This randomized, double-blind, placebo-controlled study in Alzheimer disease patients with obstructive sleep apnea shows that donepezil improves sleep apnea indices (notably AHI and oxygen saturation), increases REM sleep, and enhances cognitive performance (ADAS-cog) over 3 mon…
DOI: 10.1378/chest.07-1446 -
Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis
A systematic review and meta-analysis assessing whether oral magnesium supplementation improves insomnia symptoms in older adults, finding a potential small improvement in sleep onset latency with low-quality evidence and minimal reporting of adverse events.
DOI: 10.1186/s12906-021-03297-z